Zhang Jiangong, Xu Huifang, Zheng Liyang, Yu Juan, Chen Qiong, Cao Xiaoqin, Liu Shuzheng, Jose Gonzalez Maria, Guo Lanwei, Sun Xibin, Zhang Shaokai, Qiao Youlin
Department of Cancer Epidemiology and Prevention, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Endoscopic Diagnosis and Treatment Center, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Front Oncol. 2020 Jul 31;10:1173. doi: 10.3389/fonc.2020.01173. eCollection 2020.
Colorectal cancer (CRC) screening has been widely implemented in Europe and the USA. However, there is little evidence of participation and diagnostic yields in population-based CRC screening in China. The participation rate and detection of colorectal lesions in this program were reported and related factors were explored. The analysis was conducted in the context of the Cancer Screening Program in Urban China, which recruited 282,377 eligible participants aged 40-74 years from eight cities in Henan province from 2013 to 2019. A total of 39,834 participants were evaluated to be high risk for CRC by an established risk score system and were subsequently recommended for colonoscopy. Of 39,834 with high risk for CRC, 7,454 subjects undertook colonoscopy (participation rate of 18.71%). We found that 50-64 years, high level of education, marriage, former smoking, current alcohol drinking, low levels dietary intake of vegetables, high levels dietary intake of processed meat, lack of physical activity, fecal occult blood test positive result, history of colonic polyp, history of colorectitis, and family history of CRC were associated with increased participation of colonoscopy screening. Overall, 17 CRC (0.23%), 95 advanced adenoma (1.27%), 478 non-advanced adenomas dysplasia (6.41%), 248 hyperplastic polyp (3.33%), and 910 other benign lesions (12.21%) were detected. The findings from the study will provide important references for designing effective population-based CRC screening strategies in the future. Given the relatively low participation rate, there was room for improvement in the yield of CRC screening.
结直肠癌(CRC)筛查已在欧洲和美国广泛实施。然而,在中国基于人群的CRC筛查中,关于参与率和诊断率的证据很少。报告了该项目中结直肠病变的参与率和检测情况,并探讨了相关因素。该分析是在中国城市癌症筛查项目的背景下进行的,该项目在2013年至2019年期间从河南省的八个城市招募了282377名年龄在40 - 74岁的符合条件的参与者。通过既定的风险评分系统,共有39834名参与者被评估为CRC高风险,随后被建议进行结肠镜检查。在39834名CRC高风险者中,7454名受试者接受了结肠镜检查(参与率为18.71%)。我们发现,年龄在50 - 64岁、高学历、已婚、既往吸烟、当前饮酒、蔬菜饮食摄入量低、加工肉类饮食摄入量高、缺乏体育活动、粪便潜血试验阳性结果、结肠息肉病史、结直肠炎病史以及CRC家族史与结肠镜筛查参与率增加有关。总体而言,检测到17例CRC(0.23%)、95例高级别腺瘤(1.27%)、478例非高级别腺瘤发育异常(6.41%)、248例增生性息肉(3.33%)和910例其他良性病变(12.21%)。该研究结果将为未来设计有效的基于人群的CRC筛查策略提供重要参考。鉴于参与率相对较低,CRC筛查的检出率有提高的空间。